Literature DB >> 1219631

[Hemodynamic effects of the intravenous form of acebutolol].

J Delaye, J Pourchaire, A Gonin.   

Abstract

Acetubolol was administered intravenously to 11 patients with various heart disorders, without any adverse effects. The bradycardic effect of this compound is slight. It did not change the auriculo-ventricular conduction in 10 patients with sinus rhythm. The effect of acebutolol on myocardial efficacy is slight or absent in controls. At the doses studied, it did not alter systolic arterial pressure. Furthermore, the effect on the myocardial contractility is slight (-10 p.cent, mean). The important point noted is that the drug does not increase the pressure in ventricular filling, the first sign usually of left ventricular insufficiency caused by most other drugs of this pharmacological type.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1219631

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  1 in total

1.  ERK2-mediated phosphorylation of transcriptional coactivator binding protein PIMT/NCoA6IP at Ser298 augments hepatic gluconeogenesis.

Authors:  Bandish Kapadia; Navin Viswakarma; Kishore V L Parsa; Vasundhara Kain; Soma Behera; Sashidhara Kaimal Suraj; Phanithi Prakash Babu; Anand Kar; Sunanda Panda; Yi-jun Zhu; Yuzhi Jia; Bayar Thimmapaya; Janardan K Reddy; Parimal Misra
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.